Company Search:
Advanced Search
Sponsored Links
Anterogen Co Ltd Company Snapshot
Anterogen Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anterogen Co Ltd with three other companies in this sector in KOREA (SOUTH) : Cube&Company Co Ltd (2019 sales of 7.38 billion Korean Won [US$6.29 million] of which 98% was Synthesis), Oscotec Incorporation (4.37 billion Korean Won [US$3.73 million] of which 67% was Medical Segment), and Eyegene Inc (4.25 billion Korean Won [US$3.62 million] of which 86% was Wholesale of Medicine and Medical Suppli).

Sales Analysis. Anterogen Co Ltd reported sales of 4.15 billion Korean Won (US$3.54 million) for the year ending December of 2019. This represents an increase of 15.0% versus 2018, when the company's sales were 3.61 billion Korean Won . Despite this increase, sales are still well below the level achieved in 2017, when Anterogen Co Ltd reported sales of 5.36 billion Korean Won . Sales of Remodulins saw an increase of 20.6% in 2019, from 2.67 billion Korean Won to 3.22 billion Korean Won . Not all segments of Anterogen Co Ltd experienced an increase in sales in 2019: sales of Sevice&technical fell 97.3% to 3.00 million Korean Won . (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Anterogen Co Ltd
  Stock Performance Chart for Anterogen Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 58,600
(Figures in Korean Won )
1 Week -4.1%   13 Weeks -4.9%  
4 Weeks -21.3%   52 Weeks 40.5%  
Anterogen Co Ltd Key Data:
  Ticker: 65660 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 4,147,568,021
(Year Ending Jan 2020).
Employees: 50
  Currency: Korean Won Market Cap: 524,819,666,200
  Fiscal Yr Ends: December Shares Outstanding: 8,955,967
  Share Type: Common Closely Held Shares: 2,575,641
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.